Phathom Pharmaceuticals, Inc. (PHAT) — SC 13G/A Filings
All SC 13G/A filings from Phathom Pharmaceuticals, Inc.. Browse 3 SC 13G/A reports with AI-powered summaries and risk analysis.
SC 13G/A Filings (3)
-
Carlyle Group Updates Phathom Pharma Stake as of Dec 31, 2023
— Feb 12, 2024 Risk: low
Carlyle Group Inc. and its affiliates, including Abingworth BioVentures, filed an amended SC 13G/A on February 12, 2024, disclosing their ownership in Phathom P -
Invesco Amends Phathom Pharma Stake, Signals Portfolio Rebalance
— Feb 9, 2024 Risk: medium
Invesco Ltd. filed an amended SC 13G/A on February 9, 2024, indicating a change in their beneficial ownership of Phathom Pharmaceuticals Inc. common stock as of -
Medicxi Growth I LP Amends Phathom Pharma Stake
— Jan 26, 2024
Medicxi Growth I LP, a venture capital firm, filed an amended Schedule 13G/A on January 26, 2024, indicating a change in their beneficial ownership of Phathom P
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX